Skip to main navigation
Skip to search
Skip to main content
OSU Center for Health Sciences Research Profiles Home
Help & Contact
Link opens in a new tab
Search content at OSU Center for Health Sciences Research Profiles
Home
Profiles
Research units
Projects
Research output
Prizes
Activities
Press/Media
A case report of probable neuroleptic malignant syndrome
Alison McCullough
,
Jeffrey S. Stroup
, Nancy Brahm
Administration and Leadership
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'A case report of probable neuroleptic malignant syndrome'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adverse Drug Events
16%
Antipsychotics
33%
Arterial Blood Gas
16%
Assessment Measures
16%
Benztropine
16%
Cardiac Risk
16%
Caucasian Men
16%
Chlorpromazine
16%
Citalopram
16%
Clinical Presentation
50%
Complete Blood Count
16%
Comprehensive Metabolic Panel
16%
Cooling Blanket
16%
Dehydration
16%
Divalproex
16%
Dopaminergic Activity
16%
Dose Increase
16%
Drug Screen
16%
Emergency Department
16%
Emergency Service
16%
Etiology
16%
Genetic Susceptibility
16%
Glasgow Coma Scale
16%
Haloperidol
16%
Healthcare Professionals
16%
Hydroxyzine
16%
Hyperthermia
16%
Intensive Care Unit
16%
Medication List
16%
Medication-related
16%
Multiple Risk Factors
16%
Naranjo Adverse Drug Reaction Probability Scale
16%
Neuroleptic Malignant Syndrome
100%
Normal Limits
16%
Potential Contribution
16%
Psychiatric Comorbidity
16%
Risk Factors
33%
Serotonin Syndrome
16%
Support Measures
16%
Unknown Origin
16%
Urinalysis
16%
Nursing and Health Professions
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
16%
Adverse Drug Reaction
33%
Arterial Blood Gas
16%
Benzatropine
16%
Blood Cell Count
16%
Chlorpromazine
16%
Cholinergic Receptor Blocking Agent
16%
Citalopram
16%
Clinical Evaluation
16%
Comorbidity
16%
Dopamine Receptor Stimulating Agent
16%
Drug Dose Increase
16%
Drug Therapy
100%
Emergency Ward
16%
Genetic Susceptibility
16%
Glasgow Coma Scale
16%
Health Care Personnel
16%
Hydroxyzine
16%
Hyperthermia
16%
Intensive Care Unit
16%
Neuroleptic Malignant Syndrome
100%
Serotonin Syndrome
16%
Triage
16%
Typical Antipsychotic
33%
Urinalysis
16%
Valproate Semisodium
16%
Pharmacology, Toxicology and Pharmaceutical Science
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
16%
Adverse Drug Reaction
33%
Benzatropine
16%
Chlorpromazine
16%
Cholinergic Receptor Blocking Agent
16%
Citalopram
16%
Clinical Trial
16%
Comorbidity
16%
Dopamine Receptor Stimulating Agent
16%
Genetic Susceptibility
16%
Glasgow Coma Scale
16%
Hydroxyzine
16%
Hyperthermia
16%
Neuroleptic Malignant Syndrome
100%
Serotonin Syndrome
16%
Typical Antipsychotic
33%
Valproate Semisodium
16%
Medicine and Dentistry
Glasgow Coma Scale
16%